MADD is associated with glycemic traits (blood insulin and glucose measurement) (Masotti et al., 2019), which impacts insulin resistance in depressed people, a common risk factor for AD and frailty (Fernandes et al., 2022). This evidence concerns the gene INS and Alzheimer disease.